Oulu University Hospital is a university hospital in Oulu, Finland. It is the northernmost of the five university hospitals in Finland. The Oulu University Hospital is affiliated with the University of Oulu, and it is used as a teaching hospital by the Faculty of Medicine. The hospital was established in 1973.

During the past decade, Oulu University Hospital conducted 120 clinical trials. In the 10-year time frame, 120 clinical trials started and 15 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 62 clinical trials started and 4 clinical trials were completed. i.e. 6.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oulu University Hospital" #1 sponsor was "University of Oulu" with 57 trials, followed by "Oulu University Hospital" with 14 trials sponsored, "Helsinki University Central Hospital" with 12 trials sponsored, "Pfizer" with 7 trials sponsored and "Turku University Hospital" with 7 trials sponsored. Other sponsors include 97 different institutions and companies that sponsored additional 74 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oulu University Hospital" #1 collaborator was "Oulu University Hospital" with 40 trials as a collaborator, "Turku University Hospital" with 17 trials as a collaborator, "Helsinki University Central Hospital" with 16 trials as a collaborator, "Tampere University Hospital" with 16 trials as a collaborator and "Kuopio University Hospital" with 12 trials as a collaborator. Other collaborators include 269 different institutions and companies that were collaborators in the rest 211 trials.

According to Clinical.Site data, the most researched conditions in "Oulu University Hospital" are "Coronary Artery Disease" (6 trials), "Prostate Cancer" (6 trials), "Cancer" (4 trials), "Multiple Myeloma" (4 trials) and "Obesity" (4 trials). Many other conditions were trialed in "Oulu University Hospital" in a lesser frequency.

Most popular intervention types in "Oulu University Hospital" are "Drug" (81 trials), "Procedure" (48 trials), "Device" (37 trials), "Other" (24 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Dexamethasone" (4 trials), "Lenalidomide" (4 trials), "Rifampicin" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Oulu University Hospital" are 179 trials for "All" genders, 11 trials for "Male" genders and 9 trials for "Female" genders.

Currently, there are 85 active trials in "Oulu University Hospital". 2 are not yet recruiting, 51 are recruiting, 27 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 72 completed trials in Oulu University Hospital, 2 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Oulu University Hospital, 5 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 74 trials that are defined as “Not Applicable".